Dec 19, 2003
Genmab Files IND for HuMax-CD20 to Treat Non-Hodgkin’s Lymphoma

Dec 16, 2003
Genmab and Sanquin Collaborate to Improve Hemophilia Treatment

Dec 12, 2003
Results of Genmab’s HuMax-CD4 Phase II Psoriasis Study

Dec 8, 2003
Genmab’s HuMax-CD20 Shows Unique Properties

Dec 7, 2003
Genmab’s HuMax-CD4 Achieves Positive Results in T-Cell Lymphoma Phase II Studies

Dec 4, 2003
Grant of Warrants in Genmab A/S

Nov 17, 2003
Genmab and ACE BioSciences to Develop Product to Treat Fungal Infections

Nov 14, 2003
Genmab A/S Financial Calendar for 2004

Nov 11, 2003
Passing of Extraordinary General Meeting in Genmab A/S - Grant of Warrants

Nov 5, 2003
Genmab Announces Results for the First Nine Months of 2003

Nov 5, 2003
Genmab to Present HuMax-CD4 and HuMax-CD20 Data at American Society of Hematology Conference

Oct 28, 2003
Timing of Publication of Genmab’s Results for the First Nine Months of 2003

Oct 27, 2003
Roche and Genmab Reach Second Milestone in Collaboration

Oct 20, 2003
Genmab A/S Summons Extraordinary General Meeting

Oct 10, 2003
Grant of Warrants and Capital Increase in Genmab A/S

Sep 24, 2003
Genmab Initiates Phase I/II Trial Using HuMax-EGFr to Treat Cancer

Sep 18, 2003
Genmab to Present at UBS Global Life Sciences Conference 2003

Sep 16, 2003
Genmab Achieves Milestone in Amgen License Agreement

Aug 29, 2003
Genmab Publishes Investment Memorandum

Aug 20, 2003
Exercise of Warrants in Genmab A/S - Capital Increase

Aug 6, 2003
Genmab Announces 2003 First Half Year Results

Jul 25, 2003
Capital Increase in Genmab A/S - Directed Offering

Jul 17, 2003
Timing of Publication of Genmab’s Half-Year Results 2003

Jul 14, 2003
Genmab Expands Pipeline with Hepatitis Antibody

Jul 1, 2003
Amgen Exercises Commercial Option to Genmab’s HuMax-IL15

Jun 27, 2003
Genmab Files CTA for HuMax-EGFr to Treat Cancer

Jun 26, 2003
Genmab’s HuMax-CD20 Cancer Antibody Shows Promising Results in Primate Study

Jun 25, 2003
Grant of Warrants in Genmab A/S

Jun 11, 2003
Genmab Appoints Tatiana Brask to Investor & Public Relations Department

May 15, 2003
Genmab Completes Initial Accrual in HuMax-CD4 Phase IIb Psoriasis Study

May 7, 2003
Genmab Announces 2003 First Quarter Results

Apr 24, 2003
Passing of Genmab A/S’ Annual General Meeting

Apr 15, 2003
Genmab Announces Management Change

Apr 8, 2003
Genmab A/S Summons Annual General Meeting 2003

Mar 4, 2003
Publication of Genmab's 2002 Annual Report

Mar 4, 2003
Genmab Announces Year End 2002 Financial Results

Feb 25, 2003
Genmab to Present at the BIO CEO & Investor Conference 2003

Feb 7, 2003
Genmab Presents New HuMax-CD20 and HuMax-EGFr Pre-Clinical Data

Jan 29, 2003
US FDA Approves Genmab’s IND to Investigate HuMax-IL15 to Treat Rheumatoid Arthritis

Jan 27, 2003
US FDA Approves Genmab’s IND for HuMax-CD4 to Treat Lymphoma

Jan 9, 2003
Genmab Achieves First Milestone in Roche Antibody Collaboration

Jan 6, 2003
Genmab to Present at JPMorgan H&Q Conference 2003